Skip to main content
C

Cytecom

The startup develops microbial detection technology that utilizes membrane-potential dynamics and electrical stimulation to differentiate between viable and incapacitated cells. This enables rapid identification of life-threatening microbes in medical settings and contamination in manufacturing processes, enhancing safety and efficiency.

Coventry, United KingdomFounded 20185700+ followers
Updated 3 months ago

Funding

$850K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current microbial detection methods often require time-consuming culturing or complex labeling procedures, delaying critical interventions in healthcare and manufacturing. Existing technologies may also struggle to differentiate between viable and non-viable cells, leading to inaccurate assessments of infection risk or product contamination.

Solution

This startup offers a rapid microbial detection platform that leverages membrane-potential dynamics and electrical stimulation to distinguish between viable and incapacitated cells. By monitoring changes in cellular electrical activity in response to stimulation, the technology can quickly identify the presence and viability of microbes without the need for traditional culturing. This approach enables faster and more accurate detection of life-threatening pathogens in medical samples and contamination in manufacturing environments, improving patient outcomes and product safety. The platform's speed and sensitivity provide actionable insights for timely decision-making.

Target Audience

The primary target audience includes hospitals, diagnostic laboratories, pharmaceutical manufacturers, and food processing facilities seeking rapid and accurate microbial detection solutions.

Features

  • Real-time monitoring of microbial membrane-potential dynamics
  • Electrical stimulation to differentiate between viable and incapacitated cells
  • Culture-free detection method for rapid results
  • High sensitivity and specificity for accurate identification
  • Portable device for point-of-care or on-site testing
This profile is AI-generated and may contain inaccuracies.